Firm News: Jan. 2016: Page 2

W&L Applauds FDA Safety Concerns for Surgical Mesh in Vaginal Repair

On January 4, the U.S. Food and Drug Administration (FDA) strengthened requirements governing surgical mesh for the transvaginal repair of pelvic organ prolapse (POP). W&L hails this action as vital to addressing safety risks posed by transvaginal mesh devices. “Previously, transvaginal mesh products were classified as Class II moderate-risk medical devices, but the FDA has…

Get the Help You Need Today

Free Case Review